Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution
Brand names: Dianeal Low Calcium With Dextrose, Dianeal Pd-2 With Dextrose
Category: Renal
Not specified 18
FDA status: To Be Discontinued · Last FDA update: Aug 3, 2026 · First posted: Aug 3, 2026 · 1 manufacturers, 18 listed presentations
As of Aug 3, 2026, the FDA lists Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution as being discontinued. Of 18 manufacturer presentations, 18 Not specified.
Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0424-51) NDC 0941-0424-51 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0409-07) NDC 0941-0409-07 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0430-51) NDC 0941-0430-51 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0457-05) NDC 0941-0457-05 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0433-51) NDC 0941-0433-51 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0459-05) NDC 0941-0459-05 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0411-07) NDC 0941-0411-07 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0426-53) NDC 0941-0426-53 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0426-52) NDC 0941-0426-52 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0411-06) NDC 0941-0411-06 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0413-06) NDC 0941-0413-06 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0427-53) NDC 0941-0427-53 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0413-07) NDC 0941-0413-07 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0427-52) NDC 0941-0427-52 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0429-52) NDC 0941-0429-52 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0415-06) NDC 0941-0415-06 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0429-53) NDC 0941-0429-53 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
| DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0415-07) NDC 0941-0415-07 |
Vantive US Healthcare LLC | Not specified | A business decision was made to discontinue manufacture of the drug. |
Related medications in shortage
Other Renal medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution (FDA data as of Aug 3, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Check your inbox - click the confirmation link to activate
alerts for Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/calcium-chloride-dextrose-magnesium-chloride-sodium-5e825f.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).